Search research articles
Contact Us
Filters
Showing results (231-240 of 304) with videos related to
Page
of 31
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 19, 2024
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation
Romain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2007
New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference
Lee S Rosen, Anton J Bilchik, Robert W Beart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer
Axel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
Daniel J Sargent, Silvia Marsoni, Genevieve Monges, et al.
Pharmacogenetics and Genomics
|
December 15, 2015
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)
Adam M Lee, Qian Shi, Steven R Alberts, et al.
Nature Communications
|
June 7, 2023
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
Takayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2009
Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set
Aimery de Gramont, Joleen Hubbard, Qian Shi, et al.
The Oncologist
|
April 4, 2020
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group
Humaid O Al-Shamsi, Waleed Alhazzani, Ahmad Alhuraiji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2023
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated <i>BRAF</i><sup>V600E</sup>-Mutant Metastatic Colorectal Cancer
Eric Van Cutsem, Julien Taieb, Rona Yaeger, et al.
The Oncologist
|
May 8, 2020
In Reply
Eric A Coomes, Humaid O Al-Shamsi, Brandon M Meyers, et al.
Page
of 31
Search research articles
Search
Showing results (231-240 of 304) with videos related to
Sort By:
Page
of 31
European Journal of Cancer (Oxford, England : 1990)
|
January 19, 2024
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation
Romain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2007
New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference
Lee S Rosen, Anton J Bilchik, Robert W Beart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer
Axel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
Daniel J Sargent, Silvia Marsoni, Genevieve Monges, et al.
Pharmacogenetics and Genomics
|
December 15, 2015
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)
Adam M Lee, Qian Shi, Steven R Alberts, et al.
Nature Communications
|
June 7, 2023
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
Takayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2009
Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set
Aimery de Gramont, Joleen Hubbard, Qian Shi, et al.
The Oncologist
|
April 4, 2020
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group
Humaid O Al-Shamsi, Waleed Alhazzani, Ahmad Alhuraiji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2023
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated <i>BRAF</i><sup>V600E</sup>-Mutant Metastatic Colorectal Cancer
Eric Van Cutsem, Julien Taieb, Rona Yaeger, et al.
The Oncologist
|
May 8, 2020
In Reply
Eric A Coomes, Humaid O Al-Shamsi, Brandon M Meyers, et al.
Page
of 31